These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624 [TBL] [Abstract][Full Text] [Related]
24. Juvenile chronic myeloid leukaemia and alpha-interferon. Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286 [No Abstract] [Full Text] [Related]
25. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon]. Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238 [TBL] [Abstract][Full Text] [Related]
26. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation. Higano CS; Chielens D; Raskind W; Bryant E; Flowers ME; Radich J; Clift R; Appelbaum F Blood; 1997 Oct; 90(7):2549-54. PubMed ID: 9326220 [TBL] [Abstract][Full Text] [Related]
27. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia. Jootar S Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663 [TBL] [Abstract][Full Text] [Related]
28. Prolonged effect of alpha-interferon after discontinuance of treatment in chronic myelogenous leukemia patients. Alimena G; Montefusco E; Mancini M; De Fabritiis P; Cedrone M; Sandrelli A; Mandelli F Eur J Haematol; 1989 Aug; 43(2):108-11. PubMed ID: 2792317 [TBL] [Abstract][Full Text] [Related]
30. Interferon induced cytogenetic improvement in CGL patients in haematological relapse post allograft. Aitchison R; Collins P; Newland AC Bone Marrow Transplant; 1990 Dec; 6(6):453. PubMed ID: 2097016 [No Abstract] [Full Text] [Related]
31. Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies. Freund M; von Wussow P; Diedrich H; Eisert R; Link H; Wilke H; Buchholz F; LeBlanc S; Fonatsch C; Deicher H Br J Haematol; 1989 Jul; 72(3):350-6. PubMed ID: 2765403 [TBL] [Abstract][Full Text] [Related]
32. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases. Fayad L; Kantarjian H; O'Brien S; Seong D; Albitar M; Keating M; Talpaz M Leukemia; 1997 May; 11(5):767-71. PubMed ID: 9180306 [TBL] [Abstract][Full Text] [Related]
33. [The treatment of chronic myeloid leukemia in chronic phase with interferons]. Guilhot F Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457 [No Abstract] [Full Text] [Related]
34. Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy. Opalka B; Wandl U; Beer U; Roggenbuck U; Kloke O; Niederle N Leukemia; 1991 Jun; 5(6):452-6. PubMed ID: 2056769 [TBL] [Abstract][Full Text] [Related]
35. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia. Terebelo HR Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975 [TBL] [Abstract][Full Text] [Related]
36. Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia. Delmer A; Rio B; Bauduer F; Ajchenbaum F; Marie JP; Zittoun R Br J Haematol; 1992 Dec; 82(4):783-4. PubMed ID: 1482675 [No Abstract] [Full Text] [Related]
37. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft. Corsetti MT; Lerma E; Dejana A; Cavaliere M; Figari O; Vassallo F; Abate M; Luchetti S; Piaggio G; Parodi C; Li Pira G; Manca F; Carella AM Exp Hematol; 2000 Jan; 28(1):104-11. PubMed ID: 10658682 [TBL] [Abstract][Full Text] [Related]
38. Interferon in the treatment of chronic myeloid leukemia. Proceedings of a workshop. February 4-7, 1993, Flims, Switzerland. Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-54. PubMed ID: 8235695 [No Abstract] [Full Text] [Related]
39. Biotherapy of chronic myelogenous leukemia with interferon. Ozer H Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592 [No Abstract] [Full Text] [Related]
40. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Lee MS; LeMaistre A; Kantarjian HM; Talpaz M; Freireich EJ; Trujillo JM; Stass SA Blood; 1989 Jun; 73(8):2165-70. PubMed ID: 2730954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]